Article
Allogene's first clinical data for off-the-shelf myeloma CAR-T clouded by patient death
Rating:
0.0
Views:
31
Likes:
1
Library:
1
Allogene won't present early clinical data for its off-the-shelf multiple myeloma CAR-T therapy for another month, but a patient death in the phase 1 trial has sent its shares tumbling. The efficacy data from 15 patients are "underwhelming" compared to autologous treatments, analysts wrote, and the patient death certainly doesn't help.
Rate This Post
-
Education
-
Communication
-
Entertainment
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value